We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient ... Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. Show more
Generated quarter-over-quarter revenue growth and continued growth in procedural volume, while substantially reducing cash burn Company to report full first quarter 2024 financial results on May...
Simplifies capital structure through prepayment of existing term loan Reduces annual interest expense, providing increased near-term cash flow and operational flexibility Extends expected cash...
Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy, bariatric surgery, and weight loss devices US...
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion”), a company dedicated to ending obesity, today reported financial results for the fourth quarter and full year ended December 31, 2023, and...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audit Committee Chair, Milena Alberti-Perez...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will report financial results for the fourth quarter 2023 on Thursday, March 21, 2024...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the 44th Annual Cowen Health Care Conference, taking place on...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.47 | 26.404494382 | 1.78 | 2.3 | 1.77 | 45856 | 1.9443371 | CS |
| 4 | 0.19 | 9.22330097087 | 2.06 | 3.95 | 1.7 | 3124372 | 3.03890602 | CS |
| 12 | -0.83 | -26.9480519481 | 3.08 | 3.95 | 1.56 | 1102114 | 3.03067231 | CS |
| 26 | -1.95 | -46.4285714286 | 4.2 | 4.64 | 1.56 | 529130 | 3.04452118 | CS |
| 52 | -6.75 | -75 | 9 | 9 | 1.56 | 394458 | 3.2631629 | CS |
| 156 | -6.75 | -75 | 9 | 9 | 1.56 | 394458 | 3.2631629 | CS |
| 260 | -6.75 | -75 | 9 | 9 | 1.56 | 394458 | 3.2631629 | CS |
Monksdream
4 weeks ago
Monksdream
4 weeks ago
Monksdream
4 weeks ago
dinogreeves
4 weeks ago
dinogreeves
4 weeks ago
dinogreeves
4 weeks ago
dinogreeves
4 weeks ago
glenn1919
4 weeks ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
